Michel Moutschen

9.3k total citations
178 papers, 3.1k citations indexed

About

Michel Moutschen is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Michel Moutschen has authored 178 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 47 papers in Virology and 47 papers in Immunology. Recurrent topics in Michel Moutschen's work include HIV Research and Treatment (45 papers), HIV/AIDS drug development and treatment (32 papers) and HIV/AIDS Research and Interventions (29 papers). Michel Moutschen is often cited by papers focused on HIV Research and Treatment (45 papers), HIV/AIDS drug development and treatment (32 papers) and HIV/AIDS Research and Interventions (29 papers). Michel Moutschen collaborates with scholars based in Belgium, France and United States. Michel Moutschen's co-authors include André Scheen, Pierre Lefebvre, Philippe Léonard, Jacques Boniver, Souad Rahmouni, Alex Bollen, Étienne Sokal, Françoise Smets, Martine Denis and Michèle Haumont and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michel Moutschen

165 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Moutschen Belgium 28 967 811 708 704 579 178 3.1k
Donald D. Anthony United States 36 756 0.8× 1.3k 1.6× 1.1k 1.6× 632 0.9× 433 0.7× 128 3.9k
Maurice R.G. O’Gorman United States 31 473 0.5× 880 1.1× 592 0.8× 629 0.9× 258 0.4× 104 2.7k
Noriko Nakajima Japan 31 1.2k 1.3× 410 0.5× 987 1.4× 977 1.4× 543 0.9× 131 3.5k
Howard S. Jaffe United States 30 1.4k 1.5× 781 1.0× 313 0.4× 854 1.2× 716 1.2× 39 3.4k
Agostino Riva Italy 30 512 0.5× 814 1.0× 534 0.8× 817 1.2× 661 1.1× 122 3.0k
Jacob Nattermann Germany 36 1.9k 2.0× 1.6k 2.0× 414 0.6× 494 0.7× 415 0.7× 138 4.4k
Eugenia Quirós-Roldán Italy 32 1.1k 1.1× 712 0.9× 520 0.7× 2.0k 2.8× 484 0.8× 228 4.2k
S. Rossol Germany 30 1.5k 1.5× 904 1.1× 798 1.1× 204 0.3× 309 0.5× 101 3.4k
Jian Zheng United States 34 743 0.8× 1.8k 2.2× 645 0.9× 1.4k 1.9× 393 0.7× 105 3.8k
Robin Mogg United States 16 556 0.6× 795 1.0× 526 0.7× 596 0.8× 416 0.7× 44 2.7k

Countries citing papers authored by Michel Moutschen

Since Specialization
Citations

This map shows the geographic impact of Michel Moutschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Moutschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Moutschen more than expected).

Fields of papers citing papers by Michel Moutschen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Moutschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Moutschen. The network helps show where Michel Moutschen may publish in the future.

Co-authorship network of co-authors of Michel Moutschen

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Moutschen. A scholar is included among the top collaborators of Michel Moutschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Moutschen. Michel Moutschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moutschen, Michel, Cécile Boulanger, Joke Dehoorne, et al.. (2025). Canakinumab treatment patterns in sJIA, FMF, TRAPS, and MKD/HIDS: real-world insights from a Belgian non-interventional study. BMC Rheumatology. 9(1). 64–64.
2.
3.
4.
5.
Donneau, Anne‐Françoise, Michèle Guillaume, Vincent Bours, et al.. (2022). University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. 12(1). e055721–e055721. 7 indexed citations
6.
Collins, Patrick, et al.. (2022). [Monkeypox].. PubMed. 77(7-8). 452–455. 2 indexed citations
7.
Florence, Éric, Michel Moutschen, Jean Cyr Yombi, et al.. (2021). Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium: A multicenter, retrospective cohort. Journal of Medical Virology. 93(5). 2971–2978. 8 indexed citations
8.
Wit, Stéphane De, Éric Florence, Linos Vandekerckhove, et al.. (2018). Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients. Acta Clinica Belgica. 73(5). 341–347.
9.
Bovy, Christophe, et al.. (2017). IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrology. 18(1). 139–139. 8 indexed citations
10.
Frippiat, Frédéric, Philippe Léonard, Nadia Withofs, et al.. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. RMLG. Revue médicale de Liège. 72(12). 1 indexed citations
11.
Sauvage, Anne-Sophie, Gilles Darcis, & Michel Moutschen. (2016). Actualité thérapeutique dans le VIH : le ténofovir alafénamide. Revue Médicale Suisse. 12(527). 1367–1369. 1 indexed citations
12.
Stergiopoulou, Theodouli, Thomas J. Walsh, Mihai G. Netea, et al.. (2014). Deficiency of Interleukin-1 Receptor-associated Kinase 4 Presenting as Fatal Pseudomonas aeruginosa Bacteremia in Two Siblings. The Pediatric Infectious Disease Journal. 34(3). 299–300. 6 indexed citations
13.
Scheen, André & Michel Moutschen. (2009). Les anticorps monoclonaux en thérapeutique.. RMLG. Revue médicale de Liège. 64. 2 indexed citations
14.
Rahmouni, Souad, Torkel Vang, Andrés Alonso, et al.. (2005). Removal of C-Terminal Src Kinase from the Immune Synapse by a New Binding Protein. Molecular and Cellular Biology. 25(6). 2227–2241. 29 indexed citations
15.
Geenen, Vincent, et al.. (2003). Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. Journal of Endocrinology. 176(3). 305–311. 53 indexed citations
16.
Nkoghe, Dieudonné, Michel Moutschen, & J Demonty. (2000). Recommandations pour la prise en charge du patient infecté par le VIH. I. L'adolescent et l'adulte. Groupe de Travail de Liège sur l'Infection par le VIH.. RMLG. Revue médicale de Liège. 55(5). 2 indexed citations
17.
Jacobs, Nathalie, Alessandra Mazzoni, Delia Mezzanzanica, et al.. (1997). Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation. Cancer Immunology Immunotherapy. 44(5). 257–264. 14 indexed citations
18.
Moutschen, Michel, Dieudonné Nkoghe, Philippe Léonard, & J Demonty. (1997). Comment je traite ... une infection par le VIH. I. Bases pathogéniques des choix thérapeutiques. RMLG. Revue médicale de Liège. 52(10). 1 indexed citations
19.
Jacobs, Nathalie, Roland Greimers, Alessandra Mazzoni, et al.. (1996). Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb. Cancer Immunology Immunotherapy. 42(6). 369–375. 6 indexed citations
20.
Bontemps, J., Christian Grandfils, Michel Moutschen, Guy Dandrifosse, & Ernest Schoffeniels. (1984). Experimental set up of a fast gel filtration technique for the determination of the binding of a chemically labelled form of tetrodotoxin to its solubilized receptor from excitable tissues. Open Repository and Bibliography (University of Liège). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald D. Anthony Breakdown of academic impact, for papers by Maurice R.G. O’Gorman Breakdown of academic impact, for papers by Noriko Nakajima Breakdown of academic impact, for papers by Howard S. Jaffe Breakdown of academic impact, for papers by Agostino Riva Breakdown of academic impact, for papers by Jacob Nattermann Breakdown of academic impact, for papers by Eugenia Quirós-Roldán Breakdown of academic impact, for papers by S. Rossol Breakdown of academic impact, for papers by Jian Zheng Breakdown of academic impact, for papers by Robin Mogg
Rankless by CCL
2026